1. Home
  2. KTTA vs PRZO Comparison

KTTA vs PRZO Comparison

Compare KTTA & PRZO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

HOLD

Current Price

$0.55

Market Cap

18.1M

Sector

Health Care

ML Signal

HOLD

Logo ParaZero Technologies Ltd.

PRZO

ParaZero Technologies Ltd.

HOLD

Current Price

$0.77

Market Cap

17.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
KTTA
PRZO
Founded
2020
2014
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.1M
17.5M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
KTTA
PRZO
Price
$0.55
$0.77
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
216.1K
2.6M
Earning Date
05-14-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
77.07
N/A
EPS
N/A
N/A
Revenue
$486,559.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3130.37
N/A
52 Week Low
$0.28
$0.38
52 Week High
$2.06
$1.90

Technical Indicators

Market Signals
Indicator
KTTA
PRZO
Relative Strength Index (RSI) 62.85 67.16
Support Level $0.54 $0.76
Resistance Level $0.61 $0.82
Average True Range (ATR) 0.04 0.07
MACD 0.01 0.02
Stochastic Oscillator 92.85 59.34

Price Performance

Historical Comparison
KTTA
PRZO

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.

About PRZO ParaZero Technologies Ltd.

ParaZero Technologies Ltd operates as an aerospace defense company focused on the development of smart, autonomous solutions for the manned and unmanned aerial systems (UAS) industry. The Company develops, manufactures, markets, and sells counter-UAS net-launching platforms designed to protect against hostile drones in both battlefield and urban environments, precision aerial delivery systems for military applications, and smart, autonomous parachute safety systems designed to enable safe flight operations over populated areas and beyond visual line-of-sight. The Company sells its products internationally.

Share on Social Networks: